Most people who stop GLP-1 drugs like Ozempic eventually return
Many people prescribed GLP-1 drugs for type 2 diabetes (such as Victoza, Ozempic, or tirzepatide) stop taking them, but a surprising number later return to treatment. Researchers found that newer medications appear to keep patients on therapy longer, while side effects remain a m
Many people prescribed GLP-1 drugs for type 2 diabetes (such as Victoza, Ozempic, or tirzepatide) stop taking them, but a surprising number later return to treatment. Researchers found that newer medications appear to keep patients on therapy longer, while side effects remain a major reason for discontinuation.
This report comes from ScienceDaily. The story centres on Most people who stop GLP-1 drugs like Ozempic eventually return. Full coverage and background context is available at the original source. Readers seeking more detail on this developing topic are encouraged to follow updates from ScienceDaily and related outlets covering this beat.
